Shettar seeks probe on Indira Canteens violating quantity specifications

Bengaluru, Jun 30: In an attempt to tackle unemployment amidst covid-19 crisis, the Karnataka state government has launched a job portal connecting employers and job seekers.

The portal, 'Skill connect' ( https://skillconnect.kaushalkar.com/ ) provides region-wise and sector-wise job listings. An interested candidate can register on the portal and either apply for jobs or can also seek skill training. 

As on Monday, the portal has 25 registered companies with over 2000 jobs available in various sectors. 

The portal works more or less on similar lines as that of any private job portal, except that those posting jobs and candidates searching for employment will have to register with the Skill Development Department. 

Launching the portal on Monday, Chief Minister BS Yediyurappa hoped that the portal would provide an impetus to job creation, as well as the economic revival of the state. 

Deputy Chief Minister Dr. C.N. Ashwath Narayan who is also the skill development Minister added, "All these years, there was no information and communication between job seekers and recruiters. This portal will solve that problem."

Also, until now, there hasn't been comprehensive information either on those seeking jobs or those looking for employees. The skill development efforts have not been in sync with the market. All these issues would be addressed by the portal, he said. 

According to Karnataka Skill Development Authority Managing Director Ashwin Gowda, the portal has already seen a response with about 68 applicants in just a day. 

Officials said even the organisations will have to register with the government while providing all documents concerned. The government aims to avoid any fake job advertisements through this. "We will also enable virtual interviews between the candidate and the employer," sources in the department told DH. 

Recently, the government had also launched a portal exclusively for migrants who had returned to Karnataka from other places. This was meant to work as a skill registry.

However, the portal that was launched on Monday, went a step ahead by connecting both the prospective employers and employees, according to officials in the department.

Bengaluru, Jan 16: It was necessary to revise rates under the ECHS, CGHS and GIPSA schemes for private hospitals to be able to sustain, doctors from private hospitals have opined.

Under the banner of the Association of Healthcare Providers of India (AHPI), doctors from top private hospitals in the city spoke about the dues pending from the union government schemes. They said they could not give a deadline as to when they would stop offering the scheme.

In a press release issued here on Thursday association said, which had previously told the government that they would not treat patients under the scheme owing to dues, mellowed down after the government released Rs 250 crore out of the Rs 1,000 crore dues.

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.